Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism causes significant psychological distress in women.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Oestrogens are key for bone growth during puberty in both boys and girls.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.